Involvement of the Chemokine RANTES (CCL5) in Resistance to Experimental Infection With Leishmania Major

Infection and Immunity - United States
doi 10.1128/iai.72.8.4918-4923.2004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Oligomeric Structure of the Chemokine CCL5/RANTES From NMR, MS, and SAXS Data

2011English

The Chemokine Receptor Antagonist AOP-RANTES Reduces Monocyte Infiltration in Experimental Glomerulonephritis

Kidney International
Nephrology
1999English

Dietary Vitamin D3 Deficiency Increases Resistance to Leishmania (Leishmania) Amazonensis Infection in Mice

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2019English

The Development of a Th1-Type Response and Resistance to Leishmania Major Infection in the Absence of CD40-CD40L Costimulation

Journal of Immunology
AllergyImmunology
2001English

Mechanisms of Disease: Regulation of RANTES (CCL5) in Renal Disease

Nature Clinical Practice Nephrology
2007English

RANTES (CCL5) Regulates Airway Responsiveness After Repeated Allergen Challenge

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2006English

Pretreatment of Macrophages With the Combination of IFN-.GAMMA. And IL-12 Induces Resistance to Leishmania Major at the Early Phase of Infection

Journal of Veterinary Medical Science
Veterinary
2008English

Peripheral Neuropathic Facial/Trigeminal Pain and RANTES/CCL5 in Jawbone Cavitation

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2015English

Chemokine Gene Expression in Toll-Like Receptor-Competent and -Deficient Mice Infected With Leishmania Major

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy